• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Vet Diagn Invest . Nanopore sequencing as a rapid tool for identification and pathotyping of avian influenza A viruses

tetano

Editor, Senior Moderator
J Vet Diagn Invest


. 2021 Feb 6;1040638720984114.
doi: 10.1177/1040638720984114. Online ahead of print.
Nanopore sequencing as a rapid tool for identification and pathotyping of avian influenza A viruses


Beate M Crossley[SUP] 1 [/SUP], Daniel Rejmanek[SUP] 1 [/SUP], John Baroch[SUP] 2 [/SUP], James B Stanton[SUP] 3 [/SUP], Kelsey T Young[SUP] 3 [/SUP], Mary Lea Killian[SUP] 4 [/SUP], Mia K Torchetti[SUP] 4 [/SUP], Sharon K Hietala[SUP] 1 [/SUP]



Affiliations

Abstract

We report whole-genome sequencing of influenza A virus (IAV) with 100% diagnostic sensitivity and results available in <24-48 h using amplicon-based nanopore sequencing technology (MinION) on clinical material from wild waterfowl (n = 19), commercial poultry (n = 4), and swine (n = 3). All 8 gene segments of IAV including those from 14 of the 18 recognized hemagglutinin subtypes and 9 of the 11 neuraminidase subtypes were amplified in their entirety at >500? coverage from each of 16 reference virus isolates evaluated. Subgenomic viral sequences obtained in 3 cases using Sanger sequencing as the reference standard were identical to those obtained when sequenced using the MinION approach. An inter-laboratory comparison demonstrated reproducibility when comparing 2 independent laboratories at ≥99.8% across the entirety of the IAV genomes sequenced.

Keywords: MinION; avian influenza A virus; nanopore; whole-genome sequencing.
 
Back
Top Bottom